Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q _________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 _________________________________________________ ALBEMARLE CORPORATION ...

Exhibit 99.1 Contact: invest@albemarle.com 1.980.299.5700 Albemarle Reports First Quarter 2025 Results CHARLOTTE, N.C. – Apr. 30, 2025 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) (a) Defined as Operating Cash Flow divided by ...

Group 1 - The core investment thesis highlights a combination of strong mined lithium supply growth, a slowdown in electric vehicle (EV) sales growth in key markets, and broader market turmoil as factors contributing to the decline in Albemarle's stock price [1] Group 2 - The article indicates that Albemarle's stock price has fallen to levels not previously seen, suggesting potential undervaluation in the current market context [1]

Albemarle Corporation (ALB) is slated to release first-quarter 2025 results after the closing bell on April 30.The company missed the Zacks Consensus Estimate for earnings in each of the trailing four quarters. In this timeframe, it delivered a negative earnings surprise of 160.2%, on average. It posted a negative earnings surprise of 122.5% in the last reported quarter. ALB is likely to have benefited from its cost and productivity actions in the first quarter amid headwinds from softer lithium market pric ...

The upcoming report from Albemarle (ALB) is expected to reveal quarterly loss of $0.62 per share, indicating a decline of 338.5% compared to the year-ago period. Analysts forecast revenues of $1.17 billion, representing a decrease of 13.9% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 192.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company' ...

Albemarle (ALB) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 30. On the ...

The stock market’s sentiment gauge is no different from any other pendulum, which occasionally causes swings in either overly bullish or overly bearish sentiment.  As it turns out, President Trump's rollout of trade tariffs has caused a lot of negative talk about the broader S&P 500 index and its constituents. However, some names could be set to rebound quicker than the bears may think after uncertainties subside. Once the fog of tariff uncertainty lifts, high short-interest stocks could become prime candid ...

Albemarle (ALB) shares ended the last trading session 19.1% higher at $60.47. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 30.2% loss over the past four weeks.The rally in ALB was fueled by a broader rise in material stocks after President Trump paused reciprocal tariffs for most countries for 90 days.This specialty chemicals company is expected to post quarterly loss of $0.37 per share in its upcoming report, w ...

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...

Company Performance - Albemarle's stock closed at $58.10, reflecting a -0.7% change from the previous day, underperforming the S&P 500's daily loss of 0.23% [1] - Over the past month, Albemarle's shares have decreased by 22.51%, significantly trailing the Basic Materials sector's loss of 8.32% and the S&P 500's loss of 12.13% [1] Upcoming Earnings - The upcoming earnings report for Albemarle is scheduled for April 30, 2025, with an expected EPS of -$0.37, indicating a 242.31% decline from the same quarter last year [2] - Revenue is forecasted to be $1.2 billion, representing an 11.86% decrease compared to the same quarter of the previous year [2] Full Year Estimates - For the full year, analysts expect earnings of -$0.05 per share and revenue of $5.02 billion, which would reflect a +97.86% change in earnings and a -6.69% change in revenue from the previous year [3] - Recent changes to analyst estimates suggest evolving short-term business trends, with positive revisions indicating a favorable business outlook [3] Zacks Rank and Industry Performance - Albemarle currently holds a Zacks Rank of 3 (Hold), with a consensus EPS projection that has decreased by 14.29% in the past 30 days [5] - The Chemical - Diversified industry, which includes Albemarle, has a Zacks Industry Rank of 214, placing it in the bottom 14% of over 250 industries [6]